Skip to main content
Log in

Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New Engl J Med 2005; 352: 254–266.

    Article  CAS  Google Scholar 

  2. Falini B, Mecucci C, Saglio G, Lo Coco F, Diverio D, Brown P et al. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Haematologica 2008; 93: 439–442.

    Article  CAS  Google Scholar 

  3. Falini B, Nicoletti I, Martelli MF, Mecucci C . Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007; 109: 874–885.

    Article  CAS  Google Scholar 

  4. Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909–1918.

    Article  CAS  Google Scholar 

  5. Arber D, Brunning R, Le Beau M, Falini B, Vardiman J, Porwit A et al. Acute myeloid leukemia (AML) and related precursor neoplasms. In: IARC (ed). WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. Lyon, France, 2008, pp 109–145.

    Google Scholar 

  6. Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340–350.

    Article  CAS  Google Scholar 

  7. Pasqualucci L, Li S, Meloni G, Schnittger S, Gattenlohner S, Liso A et al. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? Leukemia 2008; 22: 1459–1463.

    Article  CAS  Google Scholar 

  8. Yin CC, Medeiros LJ, Glassman AB, Lin P . t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol 2004; 121: 836–842.

    Article  Google Scholar 

  9. Merzianu M, Medeiros LJ, Cortes J, Yin C, Lin P, Jones D et al. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol 2005; 124: 807–814.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by Centro Interdipartimentale per la Ricerca sul Cancro ‘G. Prodi’, European LeukemiaNet, COFIN 2002-2003 (Professor SA Pileri), FIRB/RFO (Professor SA Pileri and Professor PL Zinzani), AIRC, Progetto Strategico di Ateneo 2006 (Professor SA Pileri and Dr Piccaluga), Fondazione Cassa di Risparmio in Bologna, and BolognAIL grants.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P P Piccaluga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piccaluga, P., Sabattini, E., Bacci, F. et al. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. Leukemia 23, 1370–1371 (2009). https://doi.org/10.1038/leu.2009.95

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2009.95

  • Springer Nature Limited

This article is cited by

Navigation